Clorox Healthcare introduces VersaSure Cleaner Disinfectant Wipes

Article

The wipes are EPA-registered to kill 44 pathogens in two minutes or less.

Clorox Healthcare is proud to announce the latest addition to its industry-leading portfolio of healthcare disinfectants: new Clorox Healthcare® VersaSure Cleaner Disinfectant Wipes, an innovative, alcohol-free quat solution versatile enough to use on common healthcare surfaces with the assurance of broad-spectrum disinfection.

Clorox Healthcare® VersaSure™ Cleaner Disinfectant Wipes are Environmental Protection Agency (EPA) registered to kill 44 pathogens, including bacteria, viruses and fungi, in two minutes or less. The unique, low-odor, low-residue formula features patented technology that enhances quat activity on surfaces to deliver broader efficacy and faster kill times without co-actives. The result is a versatile, one-step cleaner disinfectant wipe with the speed and efficacy healthcare facilities rely on and superior esthetics, wetness and cleaning power needed for convenient, compliant use facility-wide.

Read more: 10 MAJOR infection control risks

Clorox Healthcare® VersaSure™ Cleaner Disinfectant Wipes’ innovative new formula is said to provide:

  • Speed and strength against key pathogensVersaSure is EPA-registered to kill 44 microorganisms, including 14 multi-drug resistant pathogens, in two minutes or less. VersaSure is said to kill influenza viruses, respiratory syncytial virus (RSV), measles, mumps and other viruses in 30 seconds and kill bacteria and fungi, including methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus faecalis (VRE), Escherichia coli (E. coli), salmonella, mycobacterium bovis (TB) and Candida albicans, in two minutes.

  • Excellent esthetics and cleaning power: Patented alcohol-free quat technology and innovative wipe design are engineered to combine to provide excellent esthetics, wetness and cleaning power. The low-residue formula is designed for superior staff and patient comfort with no harsh chemical fumes or odors. Durable, low-linting wipes are textured for greater strength. Excellent wetness is said to provide greater surface coverage compared with competitor quat and quat-alcohol disinfectant wipes and assurance that treated surfaces will remain wet for the full contact time.

  • Convenient, compatible use: VersaSure wipes are ready to use, fast acting and compatible with a broad range of hard, non-porous surfaces found in healthcare settings. A variety of sizes, including multipurpose wipes in 85- and 150-count canisters and 30-count flat packs, and terminal wipes for everyday cleaning and disinfecting of large spaces, available in 110-count buckets and refill pouches, makes VersaSure convenient for both nurses and environmental services teams to use facility-wide.

“Not all disinfectants are created equal and many don’t have the optimal balance of attributes to meet users’ needs. For example, a conventional quat or alcohol-based product might offer good compatibility but have limited kill claims or evaporate from surfaces before meeting the required contact time,” says Brian Thompson, department manager – R&D, Clorox Healthcare. “We believe healthcare facilities shouldn’t have to make those trade-offs and with VersaSure, they don’t. Our R&D teams refused to make compromises between efficacy, esthetics wetness and cleaning power, and today we are excited to offer a one-step, ‘use everywhere’ wipe with broad-spectrum efficacy healthcare facilities can trust.”

Trending article: What you NEED to know about single-use instruments

Building the industry’s most innovative, comprehensive portfolio of disinfecting solutions

In the fight against infections, today’s healthcare facilities need proven solutions to kill a broad range of pathogens, from seasonal threats like influenza and deadly pathogens like Clostridium difficile (C. difficile) to community-associated MRSA and new threats posed by emerging viral pathogens. Clorox Healthcare offers the industry’s most robust portfolio of EPA-registered surface disinfectants in addition to advanced UV technology as well as cleaning and odor removal products to provide healthcare facilities, nurses and EVS professionals with a comprehensive portfolio of best-in-class solutions to help reduce the risk of infections and keep patients, staff, visitors and the broader community safe.

Clorox Healthcare understands that safeguarding healthcare environments requires advanced and evolving solutions. VersaSure joins products like Clorox Healthcare® Fuzion Cleaner Disinfectant, a new type of bleach that combines disinfecting efficacy against tough-to-kill pathogens like C. difficile spores with broad surface compatibility, Clorox Healthcare® Bleach Germicidal Wipes and Clorox Healthcare® Hydrogen Peroxide Cleaner Disinfectants in a class of ready-to-use disinfectants that are tough on pathogens and optimized for surface compatibility, esthetics, ease of use, and patient and staff comfort to enable broad use, promote compliance and enhance safety facility-wide.

“At Clorox Healthcare, we are constantly innovating and working to expand the depth and breadth of our industry-leading portfolio, both by pushing the envelope with new product development and constantly striving for improvement to ensure that the mainstay surface disinfectants healthcare facilities depend on continue to meet the highest standards of efficacy and evolving needs of real-world healthcare environments,” says Lynda Lurie, director – marketing, Clorox Healthcare. “The expansion of our portfolio with the launch of VersaSure brings us one step closer to our goal of removing the environment from the infection prevention equation.”

Recent Videos
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
2024 Dental Products Report Spring Selection Bracket Reveal Video
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
Contemporary Cosmetic Dentistry – Part II: Arresting Marginal Caries
GNYDM23 Product Focus: Henry Schein Maxima Turbo Class B Sterilizer with Dyan Jayjack
GNYDM23 Product Focus: Henry Schein Maxima PowerClean 210 with Dyan Jayjack
© 2024 MJH Life Sciences

All rights reserved.